Close

Celgene's (CELG) pomalidomide receives FDA orphan drug designation for sclerosis

August 23, 2013 4:04 PM EDT Send to a Friend
Celgene's (NASDAQ: CELG) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login